Petmed Express Inc Stock: price and insider trades · United States

PetMed Express, Inc. (NASDAQ: PETS) is a U.S.-based specialty animal-health retailer operating under the PetMeds brand and, more recently, as the parent company of PetCareRx. Founded in 1996 and headquartered in Delray Beach, Florida, United States, the company is best understood as a direct-to-consumer pet pharmacy and online provider rather than a traditional drug manufacturer. Its business model focuses on convenience, competitive pricing, fast delivery, and customer service for pet owners, with sales channels that include websites, toll-free phone lines, and mobile applications. The offering spans prescription and non-prescription medications, pet food, supplements, supplies, and selected veterinary services, primarily for dogs, cats, and horses. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1040130/000104013023000033/pets-20230331.htm))

From a portfolio standpoint, PetMed Express operates in a niche segment of the broader animal-health market. The company’s product assortment has historically been broad, with approximately 10,000 pet-health SKUs disclosed in its comprehensive annual report, while a later filing referenced roughly 7,200 items, indicating a likely tightening of the assortment mix. That breadth remains important competitively because the business competes not only with other pet-specific retailers but also with generalized e-commerce platforms, brick-and-mortar chains, and veterinary channels. Its competitive edge comes from specialization, repeat purchasing behavior, and a long-standing consumer brand in pet healthcare. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000072/pets-20250331.htm))